Breaks Categories: News

ThursdayJun 02, 2022 1:11 pm

NetworkNewsBreaks – Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) Acquires Woman-Owned Cybersecurity and Info Tech Company

Cerberus Sentinel (NASDAQ: CISO), a cybersecurity consulting and managed services firm based in Scottsdale, Arizona, today announced its completion of the acquisition of Creatrix Inc., a woman-owned cybersecurity and information technology company based in Tennessee and Maryland. Under the agreement, Creatrix, which is recognized for its expertise in identity management and systems integration and software engineering, will become a wholly owned subsidiary of Cerberus Sentinel. “Creatrix is a great fit for us at Cerberus Sentinel, as we both ascribe to creating a culture of cybersecurity for our customers,” said David Jemmett, CEO and founder of Cerberus Sentinel. “We welcome co-founders…

Continue Reading

ThursdayJun 02, 2022 12:39 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Host Webinar Delving into Psychedelics Landscape, Current and Emerging Therapeutics

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that it will host a virtual Key Opinion Leader webinar from 11:00 a.m. to 12:00 p.m. ET on Thursday, June 9, 2022. The webinar will be moderated by Cybin’s Chief Executive Officer Doug Drysdale and will feature two leading experts for a discussion on the psychedelics landscape and current and emerging psychedelic-based therapeutics. Dr. John Krystal, the Robert L. McNeil, Jr., Professor of Translational Research; Professor of Psychiatry, Neuroscience and Psychology; Chair of the Department of Psychiatry at Yale University; and Chief of…

Continue Reading

ThursdayJun 02, 2022 11:38 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces $5M Registered Direct and Private Placement Offerings

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the research, development, manufacturing and commercialization of rare cannabinoids. The company today announced its entry into securities purchase agreements with a single health care-focused institutional investor for the issuance and sale of 4,079,256 of its common shares, each at a purchase price of $0.858 (or pre-funded warrant in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In a concurrent private placement, InMed has also agreed to issue and sell to the investor 1,748,250 common shares (or pre-funded warrant in lieu thereto) at the same purchase price as in…

Continue Reading

WednesdayJun 01, 2022 2:30 pm

NetworkNewsBreaks – Industrial Nanotech Inc. (INTK) Launches Shareholder Finder’s Fee Program to Encourage New Business Leads

Industrial Nanotech (OTC: INTK), a global nanoscience solutions and research leader, has unveiled a finder’s fee program for its shareholders. The company has traditionally given shareholders a fee for referrals and leads that reflect new business opportunities; the program formalizes that long-standing policy. According to the announcement, shareholders will receive 5% a referred customer’s first purchase and 2.5% on subsequent purchases under the new program. The company also started its stock buyback program. This program enables the company to repurchase shares of its common stock, with the frequency and amount of stock buyback being determined by U.S. Securities and Exchange…

Continue Reading

WednesdayJun 01, 2022 2:26 pm

NetworkNewsBreaks – Advisors Mortgage Group’s Lake Forest Branch Participates in 5K to Support Free Wheelchair Mission

Advisors Mortgage Group, based in Ocean Township, New Jersey, today announced that its Lake Forest, California, branch participated in a 5K Walk/Run for Mobility on May 22 in Newport Beach. The event raised awareness for Free Wheelchair Mission, a humanitarian, faith-based nonprofit that designs and manufactures cost-efficient, durable wheelchairs for developing countries around the world. Donating to this organization since 2015, the branch became the top sponsor in 2020. “I am deeply passionate,” said Perla Wright, Lake Forest branch manager, “about bringing mobility to people in developing countries. I have seen how the gift of a wheelchair transforms the lives…

Continue Reading

WednesdayJun 01, 2022 2:23 pm

NetworkNewsBreaks – SiGMA Announces Upcoming SiGMA Americas Summit in Toronto

SiGMA, the world’s leading hub in iGaming, including regulation, responsible gambling and marketing, will be hosting the SiGMA Americas Summit, which is slated for June 6–9, 2022. The event will be held in Toronto. According to the company, Toronto is fast becoming a North American leader in iGaming, based on its foundation of deeply supportive frameworks. According to the announcement, the premier event comes as the government has legalizing single-game sports wagering in Canada. Calling the legislation a “watershed development in the landscape of North American iGaming,” the announcement noted that the fast-growing sector features a well-established financial ecosystem and…

Continue Reading

WednesdayJun 01, 2022 1:53 pm

NetworkNewsBreaks – Vision Hydrogen Corporation (VIHD) Acquires Strategically Located Renewable Fuels Development Project

Vision Hydrogen (OTCQB: VIHD) today announced that it has acquired a 100% interest in a 14 Ha port development project for the storage and distribution of low carbon and renewable fuels, including hydrogen carriers such as ammonia, methanol and liquid organics. The project is strategically located in Vlissingen (Flushing) at the mouth of the Westerschelde estuary in the Netherlands. It is well positioned to be the first terminal in Europe with a core focus on the storage of low carbon and renewable fuels (including hydrogen carriers from which clean hydrogen may be produced) for European markets and off-takers providing carbon…

Continue Reading

WednesdayJun 01, 2022 1:48 pm

NetworkNewsBreaks – Nowigence Inc. Featured in Latest Episode of Bell2Bell Podcast

Nowigence, an innovative software-as-a-service (“SaaS”) company, was featured in the Bell2Bell Podcast, a part of IBN’s (“InvestorBrandNetwork”) sustained effort to provide specialized content distribution via widespread syndication channels. Anoop Bhatia, founder and CEO of Nowigence, joined the latest episode to discuss the company’s business model, its comprehensive AI platform, Pluaris(TM), and the growing opportunity for AI technologies. “It’s a huge market opportunity for us, and it’s also coming at a time when information is just too much for people to process manually… I think the situation is akin to when calculators were invented. They came at a time when companies…

Continue Reading

WednesdayJun 01, 2022 1:41 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports on 2022 Annual Meeting Voting

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has released a report on its recent 2022 Annual Meeting and the items that were voted on. The meeting was held on May 31, 2022, at 1 p.m. PT. According to the announcement, 2,927,321 shares of the company were represented in person or by proxy during the meeting; that number comprised 49.2% of Lexaria’s issued share capital as of April 4, 2022, which is the record date of the meeting. All matters voted on during the meeting were passed by a majority. Those matters included electing Chris Bunka, John Docherty,…

Continue Reading

WednesdayJun 01, 2022 1:32 pm

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Announces Positive Safety Findings from Clinical Trial of Concussion Drug

Odyssey Health (OTC: ODYY), formerly Odyssey Group International and a company focused on developing unique, life-saving medical products, has completed the safety evaluation for cohort 1 of its phase 1 clinical trial, which is being conducted by Nucleus Network, a leading clinical research organization. The trial studies the treatment of concussions in healthy human subjects using the company’s novel PRV-002. The company noted that the safety findings were positive and the drug was safe and well tolerated. According to the announcement, cohort 1 comprised eight healthy human volunteers who were administered a dose of PRV-002 or placebo then watched for…

Continue Reading